wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36603232-AB06D6EC-4695-4100-B5CC-4E22462186A5
Q36603232-AB06D6EC-4695-4100-B5CC-4E22462186A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603232-AB06D6EC-4695-4100-B5CC-4E22462186A5
Use of low-molecular-weight heparin to bridge therapy in obese patients and in patients with renal dysfunction.
P2860
Q36603232-AB06D6EC-4695-4100-B5CC-4E22462186A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36603232-AB06D6EC-4695-4100-B5CC-4E22462186A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a76a071dc483dab86adfb97b4e78cbc9fab914bb
P2860
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.